SPOTLIGHT -
Psychiatry Needs to Care About Climate Change: Reflections From the 2025 APA Annual Meeting
Mental health professionals recognize the profound impact of climate change on anxiety, depression, and overall well-being, urging proactive support for affected patients, says one APA attendee.
Poster at APA Annual Meeting Explores the Use of GLP-1 Agonists for Antipsychotic-Associated Metabolic Issues
Can GLP-1 agonists support patients on antipsychotics? Amir Meftah, MD, and colleagues explore its use.
Serious Mental Illness, Substance Use Disorders, and Long-Acting Injectables in the Emergency Setting
Angelo Chaia, MD, explores the impact of long-acting injectables on patients with severe mental illness and substance use disorders at the 2025 APA Annual Meeting.
Exploring New Frontiers in Depression Treatment at the APA Annual Meeting: A Call for Precision Psychiatry
At the APA Annual Meeting, Dana Hilt, MD, PhD, explores the notion of precision psychiatry in depression treatment.
New Research on Addressing Metabolic Issues Associated With Antipsychotics at APA Annual Meeting
Amir Meftah, MD, discusses the possibility of GLP-1s for addressing metabolic issues associated with antipsychotics.
Targeting Brain Cortisol: Xanamem Shows Promise in Depression and Alzheimer Disease
Dana Hilt, MD, PhD, discusses data on Xanamem’s impact on cortisol and its potential use in MDD at the APA Annual Meeting.
Beyond the Usual Psychedelic Suspects: What Psychiatrists Need to Know
What should you know about the lesser known psychedelics? Clinical insights from Jacob Perlson, MD, MPH, at the APA Annual Meeting.
Psychiatric Times Board Members Presenting at the 2025 APA Annual Meeting
Our board members are presenting at this year's APA Annual Meeting. Be sure to check out their sessions!
An Update on Early Intervention in Psychotic Disorders
An expert shares some clinical pearls from his lecture at the recent American Psychiatric Association Annual Meeting.
The Biggest APA Annual Meeting Postpandemic: Thoughts From the Scientific Program Committee
Here's everything you need to know about about the 2024 APA Annual Meeting and how to prep for next year's meeting, from members of the Scientific Program Committee.
Advice for Early Career Psychiatrists & Residents Following the APA Annual Meeting
Here's what you need to do following big conferences like the 2024 APA Annual Meeting.
H. Steven Moffic, MD, Receives Humanitarian Award at APA Annual Meeting
H. Steven Moffic, MD, received the Abraham Halpern Humanitarian Award at the 2024 American Psychiatric Association Annual Meeting. Here’s what he spoke about during his acceptance.
A Fresh Look at LSD
According to the chief medical officer of MindMed, it is time to look past the history of LSD.
Pharmacogenomics: Sticking to the Evidence Base
Pharmacogenomics at the 2024 APA Annual Meeting.
Early Career Psychiatrist Shares Thoughts on Annual Meeting
Sudhakar K. Shenoy, MD, discusses annual meeting, hot topics in child and adolescent psychiatry, and other issues in psychiatry.
AI and Virtual Psychiatry: Pros and Cons
Can you form a human bond virtually?
Bias in Record Keeping: A Real Life Example
Biases can be apparent in case notes. Psychiatric Times Editor-in-Chief sat down with us at the 2024 APA Annual Meeting to share more.
The 2024 APA Annual Meeting: Wednesday, May 8
Here are highlights from the last day of this year’s APA Annual Meeting.
What Does Humanitarian Mean?
H. Steven Moffic, MD: winner of the Abraham Halpern Humanitarian Award at the 2024 APA Annual Meeting.
Poster Explores Connections Between Suicide, Temperature at the 2024 APA Annual Meeting
“Our results indicate that prior assessments significantly underestimated the association between ambient temperature and suicide.”
Long-Acting Injectable vs Oral Antipsychotics: Part 2 of a Conversation With Peter J. Weiden, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 2 of their conversation.
Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD
Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.
The 2024 APA Annual Meeting: Tuesday, May 7
Here are highlights from the fourth day of this year’s APA Annual Meeting.
The Role of Addiction in Treatment Plans and Outcomes
The Psychiatric Times Substance Use Section Editor reflects on the theme of the 2024 Annual Meeting, plus what he is most excited about in psychiatry.
The 3 Biggest Challenges in Psychiatry Today
Philip R. Muskin, MD, MA, DLFAPA, LFACLP, discusses contemporary psychiatry and some of the most exciting things about the 2024 Annual Meeting.
Taking Data Into Real World Practice
You no longer have to trade physical health for mental health.
The Art of Storytelling and Psychiatry
The series editor of Tales From the Clinic stresses the importance of clinical case studies.
The Inpatient Setting vs the Time of the Year in Hospitalized Child and Adolescent Patients
Rikinkumar Patel, MD, MPH, shares some recent research findings with Psychiatric Times at the 2024 Annual Meeting.
Creativity and Burnout as a Clinician
Do you use art as part of your clinical practice?
Experts Shed Light on Workplace Violence in Health Care Settings
Laura T. Safar, MD, led a discussion on the prevalence and prevention of violence in the workplace.